Diphenoxylate is an antidiarrheal medication classified as a synthetic opioid agonist, primarily utilized in combination therapies to manage symptoms of acute and chronic diarrhea by binding to mu-opioid… Read more
Diphenoxylate is an antidiarrheal medication classified as a synthetic opioid agonist, primarily utilized in combination therapies to manage symptoms of acute and chronic diarrhea by binding to mu-opioid receptors in the gastrointestinal tract to decrease intestinal motility. To ensure the safety and efficacy of pharmaceutical formulations containing this active ingredient, rigorous analytical testing is essential throughout the drug development lifecycle. Laboratories utilize specialized reference standards, including impurities such as Diphenoxylate EP Impurity B, to perform comprehensive impurity profiling and validate analytical methods. Furthermore, stable isotope labelled compounds are critical tools for researchers conducting precise quantitative analysis and pharmacokinetic studies. By incorporating these high-quality reference materials, analysts can accurately detect, identify, and quantify impurities or metabolites, ensuring compliance with pharmacopeial standards and maintaining strict quality control across all production stages of this antidiarrheal agent.